Source: Supplemental, short-protocol MRI a cost-effective addition for stroke patients in the ED

Astellas’ $3 billion bet on Audentes Therapeutics has hit yet another setback. Months after getting a clinical hold lifted, Astellas has voluntarily paused a gene therapy clinical trial after a patient suffered liver problems at the lower, supposedly safer dose. Source: After cutting dose because of deaths, Astellas pauses gene therapy trial as new liver...

COVID-19 wasn’t even in the picture when mRNA was developed, but with the regulatory runway cleared, biotechs that have been working on the tech for years are ready for liftoff. Yes, Moderna and BioNTech are the rock stars in the business—launched to household name status with the COVID-19 vaccines at the end of 2020. But...

Download this whitepaper to learn more. Source: How Digital Transformation Can Lead the Evolution of Pharmaceutical Operations Free White Paper

Through world-leading genetic work, NSW researchers are discovering why about 50% of melanomas don’t respond to immunotherapy. Over the past decade, immunotherapy drugs have become the standard treatment for metastatic (or Stage IV) melanomas. These drugs help someone’s immune system recognise and fight a tumour by preventing tumour cells from obstructing the body’s immune checkpoints....

Source: Artificial intelligence predicts delayed radiology turnaround times during nights and weekends

A leading group of NSW experts will pioneer Australia-first research to inform vaccine policy in the state and beyond. The Vaccine, Infection and Immunology (VIIM) Collaborative Research Group will receive more than $4.5 million in funding from the NSW Government over three years to study the clinical and immunological responses to COVID-19 vaccines in NSW...

Source: AI cuts average CCTA reading time by 73%, helping radiologists detect coronary artery disease

A new study in Ultrasound in Medicine and Biology shows that ultrasound can accurately diagnose hand injuries, specifically tendon tears, further proving Source: Ultrasound Can Accurately Diagnose Common Hand Injuries – HealthManagement.org

Nivolumab gets FDA approval for those at high risk of recurrence after surgery Source: PD-1 Inhibitor OK’d as Adjuvant Therapy for Bladder Cancer | MedPage Today